(Press-News.org) Contact information: Dr. Salvador Macip
sm460@le.ac.uk
01-162-297-113
University of Leicester
Breakthrough announced in treatment of patient with rare type of leukemia
University of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug
A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer.
The research, which is published today (Thursday 16 January) in the New England Journal of Medicine, indicates Vemurafenib, a BRAF inhibitor that has been approved as a treatment for advanced melanomas, is also successful in treating leukaemia. The study shows the treatment, which can be taken orally, cleared the malignant cells from the patient's blood and led to a complete clinical recovery in a number of days.
The study was led by the University of Leicester and involved treatment of a patient at the Leicester Royal Infirmary.
Dr Salvador Macip, from the University of Leicester's Department of Biochemistry, explained: "A genetic study of the patient's blood cells allowed us to identify a mutation in the BRAF gene that is commonly found in skin cancers. This knowledge enabled us to combat the cancer cells with Vemurafenib, which has had proven success as a BRAF inhibitor in melanomas, and showed similar success for this patient who had exhausted all other treatment options, which is fantastic.
"What was most surprising was that the drug did not work in the way we expected it to. Whilst it successfully blocked BRAF and killed the cancerous cells, there was no ability to block the downstream cascade of signals. Therefore more research is required to better understand how this drug works to ensure we are able to use it in the best possible way.
"This is one of the first clinical examples of this treatment for HCL and we are the first researchers to do a biochemical study of the samples and discover that the drug does not do what it's supposed to be doing."
This approach to targeting cancer is an example of precision medicine with clinicians and research scientists working side-by-side to ensure the best treatment, tailored to the individual patient, was provided.
Professor of Haemato-Oncology at the University of Leicester, Professor Martin Dyer, who is Honorary Consultant Physician, Department of Haematology at Leicester's Hospitals, said: "Precision medicine in which clinicians and basic scientists collaborate to deliver novel and rapid personalised therapies to cancer patients like this is essential.
"We drew blood from the patient on a daily basis which was analysed back in the lab to monitor the effects of the drug. The more understanding we have of how treatments such as Vemurafenib kill cancer cells, the more effective and targeted treatments can be."
Professor Dyer is based in the University of Leicester's Department of Cancer Studies and Molecular Medicine and the treatment of the patient took place at the Leicester Royal Infirmary.
This research shows that drugs currently used to target certain cancers could be applied in other malignancies that share similar genetic backgrounds.
University of Leicester Pro-Vice-Chancellor and Head of the College of Medicine, Biological Sciences and Psychology, Professor David Wynford-Thomas, said: "The importance of the close working partnership between the University of Leicester and Leicester's Hospitals is highlighted in advances such as this. World-class research at the University brings direct benefits to patients in Leicester's hospitals in diverse areas including cardiovascular health, kidney research, lung health, diabetes, cancer research and many other areas.
"I am delighted that our research has had such a direct benefit locally - it is another first for the University of Leicester and Leicester Royal Infirmary."
INFORMATION:
Breakthrough announced in treatment of patient with rare type of leukemia
University of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug
2014-01-16
ELSE PRESS RELEASES FROM THIS DATE:
A deeper look at interfaces
2014-01-16
A deeper look at interfaces
Researchers at Berkeley Lab's Advanced Light Source develop new technique for probing subsurface electronic structure
"The interface is the device," Nobel laureate Herbert Kroemer famously observed, referring to the remarkable ...
Trees grow faster and store more carbon as they age
2014-01-16
Trees grow faster and store more carbon as they age
Trees put on weight faster and faster as they grow older, according to a new study in the journal Nature. The finding that most trees' growth accelerates as they age suggests that large, old trees may ...
2 diabetes studies in Jan. 2014 Health Affairs
2014-01-16
2 diabetes studies in Jan. 2014 Health Affairs
Jan. articles examine the toll of diabetes, both in the US and abroad
Poorer Americans: depleted food budgets can mean higher risk of hypoglycemia.
For generations, economists have noted that low-income households spend much ...
Researchers discover that coevolution between humans and bacteria reduces gastric cancer risk
2014-01-16
Researchers discover that coevolution between humans and bacteria reduces gastric cancer risk
Research carried out in two distinct communities in Colombia illustrates how coevolution between humans and bacteria can affect a person’s risk ...
New analysis shows fewer years of life lost to cancer
2014-01-16
New analysis shows fewer years of life lost to cancer
Dartmouth researchers say US has underestimated its progress in war on cancer
(Lebanon, NH, 1/15/14) - Since the enactment of the National Cancer Act in 1971, the U.S. has spent hundreds ...
Ray of hope for magazines in digital era
2014-01-16
Ray of hope for magazines in digital era
Targeted audiences and websites can help magazines weather the onslaught of online competition
There is a ray of hope for magazines that do it right.
While print media continue to suffer at the hands of their online counterparts, ...
Resisting the flu
2014-01-16
Resisting the flu
New avenues for influenza control suggested by identification of an enzyme that plays a crucial role in resistance to the infection
McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the ...
Next-gen reappraisal of interactions within a cancer-associated protein complex
2014-01-16
Next-gen reappraisal of interactions within a cancer-associated protein complex
Application of global sequencing technology reveals how an activator of gene expression stays focused
KANSAS CITY, MO- At a glance, DNA is a rather simple sequence of A, ...
Hugging hemes help electrons hop
2014-01-16
Hugging hemes help electrons hop
Novel biological mechanism relays electrons in proteins in mineral-breathing bacteria important for energy-related research
RICHLAND, Wash. -- Researchers simulating how certain bacteria run electrical current ...
Nationwide minimally invasive surgery rates triple for pancreatic disease
2014-01-16
Nationwide minimally invasive surgery rates triple for pancreatic disease
Researchers at University of California, San Diego School of Medicine report a three-fold increase in the use of minimally invasive surgery (MIS) across the nation for patients ...
LAST 30 PRESS RELEASES:
Transgene-free genome editing in poplar trees: A step toward sustainable forestry
Single-dose psychedelic boosts brain flexibility for weeks, peer-reviewed study finds
Sex differences drive substance use patterns in panic disorder patients
Multi-omics meets immune profiling in the quest to decode disease risk
Medication-induced sterol disruption: A silent threat to brain development and public health
Shining a light on DNA: a rapid, ultra-sensitive, PCR-free detection method
European hares are thriving in the city: New monitoring methods reveal high densities in Danish urban areas
Study: middle-aged Americans are lonelier than adults in other countries, age groups
World’s leading science competition identifies 19 breakthrough solutions around the globe with greatest potential to tackle the planetary crisis
Should farm fields be used for crops or solar? MSU research suggests both
Study: Using pilocarpine drops post goniotomy may reduce long-term glaucoma medication needs
Stanford Medicine researchers develop RNA blood test to detect cancers, other clues
Novel treatment approach for language disorder shows promise
Trash talk: As plastic use soars, researchers examine biodegradable solutions
Using ChatGPT, students might pass a course, but with a cost
Psilocibin, or “magic mushroom,” use increased among all age groups since decriminalization in 2019
More Americans are using psilocybin—especially those with mental health conditions, study shows
Meta-analysis finds Transcendental Meditation reduces post-traumatic stress disorder (PTSD) symptoms across populations and cultures
AACR: Five MD Anderson researchers honored with 2025 Scientific Achievement Awards
How not to form a state: Research reveals how imbalanced social-ecological acceleration led to collapse in early medieval Europe
Introduced trees are becoming more common in the eastern United States, while native diversity declines
The chemical basis for life can form in interstellar ice
How safe is the air to breathe? 50 million people in the US do not know
DDT residues persist in trout in some Canadian lakes 70 years after insecticide treatment, often at levels ten times that recommended as safe for the wildlife which consumes the fish
Building ‘cellular bridges’ for spinal cord repair after injury
Pediatric Academic Societies awards 33 Trainee Travel Grants for the PAS 2025 Meeting
Advancing understanding of lucid dreaming in humans
Two brain proteins are key to preventing seizures, research in flies suggests
From research to real-world, Princeton startup tackles soaring demand for lithium and other critical minerals
Can inpatient psychiatric care help teens amid a depressive crisis?
[Press-News.org] Breakthrough announced in treatment of patient with rare type of leukemiaUniversity of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug